The Vanguard Network Announces Virtual Session on R&D Tax Credits and the Current Landscape for Life Sciences

The Vanguard Network is pleased to announce its upcoming session, “R&D Tax Credits and the Current Landscape for Life Sciences,” taking place December 9, 2025, from 11:00 AM to 12:00 PM EST.

With major policy changes taking effect in 2025, life sciences companies are facing new complexities in determining what qualifies for R&D tax credits and how to stay compliant amid evolving regulatory expectations. This session will provide clarity and practical guidance for leaders across biotech, pharma, and medical devices.

Experts from alliantgroup—Dr. Jordan Jahrling, Associate Director and Life Sciences Practice Lead, and Neil Shah, Senior Director—will break down:

• What qualifies as R&D in today’s life science environment

• Eligibility for clinical trials, software and bioinformatics, and process development

• Key 2025 updates, including expensing rules and documentation requirements

• IRS priorities under the new administration

• Common audit pitfalls and how companies successfully defend claims

Part of the Berkley Life Sciences CEO Series, this conversation will offer actionable insights, real-world cases, and open dialogue—no podium, no PowerPoint, no presentations.

To learn more and sign up, click here.

About The Vanguard Network

The Vanguard Network is a leadership community and advisory platform that helps senior executives sharpen foresight, strengthen performance, and achieve impact. Through forums, exchanges, and programs, Vanguard convenes leaders across industries to share challenges and solutions in a confidential, collaborative setting.